- Category
- Micro (2024-25)
- Udyam number
- UDYAM-TN-09-0019227

Marthahan Pharma Private Limited
About Marthahan Pharma Private Limited
Data last updated:
Marthahan Pharma Private Limited is a private limited company based in Nagercoil, Tamil Nadu, India. It operates in the manufacturing segment of the chemicals sector. It was incorporated on 07 March 2019 and has been in existence for over 7 years.
The company is registered with the Registrar of Companies (ROC), Chennai, under CIN U24290TN2019PTC127889. Its GSTIN is 33AAMCM5049A1ZQ (Tamil Nadu). The company holds 2 GST registrations, all of them active.
The company has an authorised share capital of ₹25 Lakh and a paid-up capital of ₹25 Lakh. It is led by directors Neelamarthandan Mohan Neela Judith (Managing Director) and Amarjothi Jeffry Chhibber.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at No. 44 Court Road, Nagercoil, Tamil Nadu, India – 629001.
As per the financials filed for FY 2025, the company reported a revenue of ₹72.77 Lakh, a decline of 40% compared to the previous year. For the same year it recorded a net loss of ₹4.17 Lakh (net margin -5.7%) and EBITDA of -₹2.76 Lakh (EBITDA margin -3.8%). Revenue has grown at a compounded annual rate (CAGR) of 22% over three years and 118% over five years.
The company has about 9 employees on its provident fund (EPFO) records.
Marthahan Pharma Private Limited is registered as a micro enterprise under the Udyam registration framework (Reg. No. UDYAM-TN-09-0019227).
Company details
Recognitions & Rankings of Marthahan Pharma
Contact details
Marthahan Pharma Private Limited's registered office is in Nagercoil, Tamil Nadu. Its e-mail address is in the company report.
- Email
- Registered AddressNo. 44 Court Road, Nagercoil, Tamil Nadu, India – 629001
- IndustryChemicals, Manufacturing, Other Chemical Product
To see the full contact details of Marthahan Pharma Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Business activity
The main business activity of Marthahan Pharma is manufacturing. In detail, this covers chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| C | Manufacturing | C6 | Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products |
To see the full business activity and turnover split of Marthahan Pharma Private Limited, buy the company report.
Financials of Marthahan Pharma Private Limited
FY 2025 filings availableMarthahan Pharma Private Limited reported revenue of ₹72.77 Lakh (down 40% YoY) for FY 2025.
Compounded Annual Growth Rate (CAGR)
Revenue fell 40% in the latest year, but over five years it has grown at a compounded annual rate (CAGR) of 118%. EBITDA rose 97% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | -₹2.76 Lakh | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | -₹4.17 Lakh | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | -3.8% | ||||
| Net Profit Margin | -5.7% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Marthahan Pharma Private Limited, buy the company report.
Board of directors of Marthahan Pharma Private Limited
Marthahan Pharma has 2 directors on record. No former directors are listed.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Neelamarthandan Mohan Neela Judith | Managing Director | 07 Mar 2019 | 7 Years 7 Months | Current |
| Amarjothi Jeffry Chhibber | Director | 07 Mar 2019 | 7 Years 7 Months | Current |
Peer comparison
Marthahan Pharma Private Limited is compared with the 10 companies closest to it by revenue in the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Livsafe Products Private Limited | ₹73.03 Lakh (FY 2025) | 217.0% | Kanpur, Uttar Pradesh, India | |||
| J & S Ayurveda Products Private Limited | ₹73.03 Lakh (FY 2025) | Kolkata, West Bengal, India | ||||
| Nsynth Labs Private Limited | ₹73.01 Lakh (FY 2022) | -43.0% | Hyderabad, Telangana, India | |||
| Qualimed Bioscience Private Limited | ₹72.93 Lakh (FY 2024) | 122.0% | Ghatlodiya, Ahmedabad, Gujarat, India | |||
| Dr.Cpr Lifesciences Private Limited | ₹72.87 Lakh (FY 2016) | 201.0% | Hyderabad, Telangana, India | |||
| Marthahan Pharma Private Limitedthis company | ₹72.77 Lakh (FY 2025) | -₹4.17 Lakh | -5.7% | -40.0% | 9 | Nagercoil, Tamil Nadu, India |
| Jankalyan Sales Private Limited | ₹72.73 Lakh (FY 2025) | 171.0% | Aurangabad, Maharashtra, India | |||
| Rumart (India) Private Limited | ₹72.69 Lakh (FY 2025) | 2188.0% | Jabalpur, Madhya Pradesh, India | |||
| Amo Detergent Private Limited | ₹72.49 Lakh (FY 2021) | 21.0% | Kolkata, West Bengal, India | |||
| Gufic Chem Private Limited | ₹72.48 Lakh (FY 2024) | -63.0% | Belgaum, Karnataka, India | |||
| Camy Drugs & Chemicals Private Limited | ₹72.44 Lakh (FY 2025) | 10.0% | Karnal, Haryana, India |
To see the full peer comparison of Marthahan Pharma Private Limited, buy the company report.
Legal cases
No court or tribunal cases involving Marthahan Pharma Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Marthahan Pharma Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
Employees & EPFO
Marthahan Pharma Private Limited has a workforce of 9 employees on its EPFO records as of Apr 10, 2024, across 1 active EPFO establishment.
GST
Marthahan Pharma has 2 GST registrations: 2 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 33AAMCM5049A1ZQ | Tamil Nadu | Active | 21 May 2019 |
| 29AAMCM5049A1ZF | Karnataka | Active | 19 Jun 2019 |
To see the full GST registrations and return filing status of Marthahan Pharma Private Limited, buy the company report.
Recent activity
Marthahan Pharma Private Limited has 2 board changes on record since 2019: 2 appointments. The latest: Amarjothi Jeffry Chhibber was appointed as Director on 07 Mar 2019.
Frequently asked questions
Marthahan Pharma is an active private limited company based in Nagercoil, Tamil Nadu, India. The company works in manufacturing, within the chemicals industry. It was incorporated on 07 March 2019 (7+ years old) and is registered under CIN U24290TN2019PTC127889.
Marthahan Pharma has 2 current directors:
- Neelamarthandan Mohan Neela Judith - Managing Director
- Amarjothi Jeffry Chhibber - Director
The latest financial statements of Marthahan Pharma on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from FY 2019 are in the company report.
The GSTIN of Marthahan Pharma is 33AAMCM5049A1ZQ, registered in Tamil Nadu. The company has 2 GST registrations in all, of which 2 are active. Other active GSTINs include 29AAMCM5049A1ZF (Karnataka).
The CIN (Corporate Identification Number) of Marthahan Pharma is U24290TN2019PTC127889. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Marthahan Pharma was incorporated on 07 March 2019, making it 7+ years old. It is registered with the Registrar of Companies, Chennai.
The peers of Marthahan Pharma by revenue are Livsafe Products Private Limited, J & S Ayurveda Products Private Limited, Nsynth Labs Private Limited, Qualimed Bioscience Private Limited, Dr.Cpr Lifesciences Private Limited and 5 more, all in the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products).
Amarjothi Jeffry Chhibber was appointed as Director on 07 Mar 2019. Neelamarthandan Mohan Neela Judith was appointed as Managing Director on 07 Mar 2019.
Yes, Marthahan Pharma is registered as a micro enterprise under Udyam registration (number: UDYAM-TN-09-0019227).
The registered office of Marthahan Pharma is at No. 44 Court Road, Nagercoil, Tamil Nadu, India – 629001.
Marthahan Pharma operates in the chemicals industry, in the manufacturing segment.